Observations placeholder

Bethanechol is a parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors without any effect on nicotinic receptors. Unlike acetylcholine, bethanechol is not hydrolyzed by cholinesterase and will therefore have a long duration of action. Bethanechol is sold under the brand names Duvoid, Myotonachol, Urecholine  and Urocarb.

Uses

Bethanechol alleviates dry mouth and is sometimes given orally or subcutaneously to treat urinary retention resulting from general anesthetic, diabetic neuropathy of the bladder, or a side effect of antidepressants; or to treat gastrointestinal lack of muscular tone. The muscarinic receptors in the bladder and gastrointestinal tract stimulate contraction of the bladder and expulsion of urine, and increased gastrointestinal motility, respectively. Bethanechol should be used to treat these disorders only after mechanical obstruction is ruled out as a possible cause.

Its potential benefit in the treatment of cerebral palsy has been investigated. Bethanechol is a powerful cholinergic agent which does not cross the blood - brain barrier and may have powerful nootropic properties in enhancement of neural signaling and processing speed as well.

Atropine is given preoperatively to prevent voiding of the bowel/bladder during surgery, Bethanechol is then given postoperatively to revert this action.

On Feb, 18, 2016: 330 people reported to have side effects when taking Urecholine. Among them, 13 people (3.94%) have Hallucination.

On Feb, 18, 2016: 330 people reported to have side effects when taking Urecholine. Among them, 13 people (3.94%) have Death.

Time on Urecholine when people have Death  :

Gender of people who have Death when taking Urecholine  :

Age of people who have Death when taking Urecholine  :

Top conditions involved for these people  :

1. Anxiety (7 people, 53.85%)
2. Depression (6 people, 46.15%)
3. Nervousness (6 people, 46.15%)
4. Insomnia (6 people, 46.15%)